The structure of Escherichia coli cytosine deaminase

被引:123
作者
Ireton, GC
McDermott, G
Black, ME
Stoddard, BL
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Univ Washington, Grad Program Mol & Cell Biol, Seattle, WA 98109 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Nal Lab Adv Light Source, Berkeley, CA 94720 USA
[4] Washington State Univ, Coll Pharm, Dept Pharmaceut, Pullman, WA 99164 USA
关键词
cytosine deaminase; prodrug gene therapy; protein structure; X-ray crystallography; enzyme mechanism;
D O I
10.1006/jmbi.2001.5277
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytosine deaminase (CD) catalyzes the deamination of cytosine, producing uracil. This enzyme is present in prokaryotes and fungi (but not multicellular eukaryotes) and is an important member of the pyrimidine salvage pathway in those organisms. The same enzyme also catalyzes the conversion of 5-fluorocytosine to 5-fluorouracil; this activity allows the formation of a cytotoxic chemotherapeutic agent from a non-cytotoxic precursor. The enzyme is of widespread interest both for antimicrobial drug design and for gene therapy applications against tumors. The structure of Esclierichia coli CD has been determined in the presence and absence of a bound mechanism-based inhibitor. The enzyme forms an (up), barrel structure with structural similarity to adenosine deaminase, a relationship that is undetectable at the sequence level, and no similarity to bacterial cytidine deaminase. The enzyme is packed into a hexameric assembly stabilized by a unique domain-swapping interaction between enzyme subunits. The active site is located in the mouth of the enzyme barrel and contains a bound iron ion that coordinates a hydroxyl nucleophile. Substrate binding involves a significant conformational change that sequesters the reaction complex from solvent. (C) 2002 Academic Press.
引用
收藏
页码:687 / 697
页数:11
相关论文
共 43 条
[21]   TRANSITION-STATE STABILIZATION BY ADENOSINE-DEAMINASE - 1,6-ADDITION OF WATER TO PURINE RIBONUCLEOSIDE, THE ENZYMES AFFINITY FOR 6-HYDROXY-1,6-DIHYDROPURINE RIBONUCLEOSIDE, AND THE EFFECTIVE CONCENTRATION OF SUBSTRATE WATER AT THE ACTIVE-SITE [J].
JONES, W ;
KURZ, LC ;
WOLFENDEN, R .
BIOCHEMISTRY, 1989, 28 (03) :1242-1247
[22]   CYTOSINE DEAMINASE FROM ESCHERICHIA-COLI - PRODUCTION, PURIFICATION, AND SOME CHARACTERISTICS [J].
KATSURAGI, T ;
SAKAI, T ;
MATSUMOTO, K ;
TONOMURA, K .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1986, 50 (07) :1721-1730
[23]   IMPLANTABLE ENZYME CAPSULES FOR CANCER-CHEMOTHERAPY FROM BAKERS-YEAST CYTOSINE DEAMINASE IMMOBILIZED ON EPOXY-ACRYLIC RESIN AND URETHANE PREPOLYMER [J].
KATSURAGI, T ;
SAKAI, T ;
TONOMURA, K .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1987, 16 :61-69
[24]  
Kievit E, 1999, CANCER RES, V59, P1417
[25]   ADENOSINE-DEAMINASE CONVERTS PURINE RIBOSIDE INTO AN ANALOG OF A REACTIVE INTERMEDIATE - A C-13-NMR AND KINETIC-STUDY [J].
KURZ, LC ;
FRIEDEN, C .
BIOCHEMISTRY, 1987, 26 (25) :8450-8457
[26]   Automated refinement for protein crystallography [J].
Lamzin, VS ;
Wilson, KS .
MACROMOLECULAR CRYSTALLOGRAPHY, PT B, 1997, 277 :269-305
[27]   AUTOMATED REFINEMENT OF PROTEIN MODELS [J].
LAMZIN, VS ;
WILSON, KS .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1993, 49 :129-147
[28]   PROCHECK - A PROGRAM TO CHECK THE STEREOCHEMICAL QUALITY OF PROTEIN STRUCTURES [J].
LASKOWSKI, RA ;
MACARTHUR, MW ;
MOSS, DS ;
THORNTON, JM .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1993, 26 :283-291
[29]   CRYSTALLOGRAPHIC ANALYSIS OF THE COMPLEX BETWEEN TRIOSEPHOSPHATE ISOMERASE AND 2-PHOSPHOGLYCOLATE AT 2.5-A RESOLUTION - IMPLICATIONS FOR CATALYSIS [J].
LOLIS, E ;
PETSKO, GA .
BIOCHEMISTRY, 1990, 29 (28) :6619-6625
[30]   XtalView Xfit - A versatile program for manipulating atomic coordinates and electron density [J].
McRee, DE .
JOURNAL OF STRUCTURAL BIOLOGY, 1999, 125 (2-3) :156-165